F5, Inc. Total Cost of Revenue decreased by 0.6% to $150.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $140.96M to $150.90M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $120.90M | $128.68M | $135.07M | $126.36M | $130.73M | $147.46M | $155.01M | $155.65M | $141.68M | $140.96M | $136.39M | $141.11M | $136.43M | $143.72M | $140.51M | $140.96M | $148.63M | $143.88M | $151.79M | $150.90M |
| QoQ Change | — | +6.4% | +5.0% | -6.5% | +3.5% | +12.8% | +5.1% | +0.4% | -9.0% | -0.5% | -3.2% | +3.5% | -3.3% | +5.3% | -2.2% | +0.3% | +5.4% | -3.2% | +5.5% | -0.6% |
| YoY Change | — | — | — | — | +8.1% | +14.6% | +14.8% | +23.2% | +8.4% | -4.4% | -12.0% | -9.3% | -3.7% | +2.0% | +3.0% | -0.1% | +8.9% | +0.1% | +8.0% | +7.1% |